In addition, hepatic STING mRNA expression was positively correlated with several characteristic NAFLD parameters, such as liver enzyme levels, hepatic TLR9 mRNA expression, and microbiota-derived bile acid levels. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.